Miraca Whistleblower Stops Bid to Arbitrate Retaliation Claim

Miraca Life Sciences Inc. waived its chance to argue that a False Claims Act whistleblower’s retaliation claim should be resolved in arbitration, the U.S. Court of Appeals for the Sixth Circuit said.

Paul Dorsa filed an FCA suit accusing Miraca, a laboratory company which is now Inform Diagnostics Inc., of filing Medicare claims that were tainted by kickbacks in 2013. His suit led to a $63.5 million settlement in 2019 that didn’t cover his retaliation claim, the court said.

Miraca asserted that Dorsa’s employment agreement with the company required the retaliation claim to be resolved by an arbitrator, not a ...